The U.S. Food and Drug Administration has announced a voluntary nationwide recall of 25,000 bottles of a common blood pressure medication. The move follows laboratory tests showing that certain tablets fail to dissolve properly, which could mean patients aren't getting the full dose they need to control their hypertension.
This recall specifically affects chlorthalidone 25 mg tablets, a diuretic often called a "water pill" that helps the kidneys remove excess fluid and salt. The manufacturer, India-based Inventia Healthcare Limited, distributed the affected bottles in 100-tablet containers across the country. The recall is classified as Class II, meaning the product may cause temporary or medically reversible health consequences, but the risk is still serious enough to warrant immediate action.
Why the dissolution failure matters
When a tablet doesn't break down as designed, the active ingredient may not be released at the right time or in the right amount. For a medication like chlorthalidone, that could leave your blood pressure inadequately controlled, increasing the risk of heart attack, stroke, and other complications. The Centers for Disease Control and Prevention notes that high blood pressure contributed to more than 680,000 deaths in the U.S. in 2024 alone.
This isn't the first time Inventia has faced this issue. A similar recall in June involved 11,460 bottles under the same circumstances. Now, with this latest batch, health officials are urging everyone to check their medicine cabinets immediately.
How to identify the recalled bottles
Look for the lot number RISA24002 and the NDC code 64980-599-01. The affected bottles have an expiration date of April 2027. If you find these details on your prescription, stop taking the medication and contact your healthcare provider or pharmacist right away. Do not stop your treatment without a doctor's guidance—they can help you switch to a safe alternative.
This recall is part of a broader pattern of regulatory vigilance. Just last month, the FDA also pulled a weight loss supplement after discovering undeclared ingredients. For Latino families, many of whom manage chronic conditions like hypertension, staying informed about these alerts is crucial. Check your mail for other important notices that might affect your household.
What patients should do now
- Inspect every bottle of chlorthalidone you have at home, including those stored in travel bags or at work.
- If you have the recalled lot, do not take the tablets. Instead, return them to your pharmacy or follow local disposal instructions.
- Contact your doctor to arrange a replacement medication. Never adjust your dose on your own.
- Keep monitoring your blood pressure with a certified home device and record your readings for your next appointment.
- Share this information with family and friends who may also be taking this medication.
Pharmacies and distributors are working to remove the defective bottles from shelves, and consumer support lines are open for anyone with questions. The FDA's recall number for this action is D-0852-2026.
For many in our community, managing blood pressure is a daily reality. Taking a few minutes to verify your medication could make a significant difference in your health. Other recalls have also affected everyday products, so it's wise to stay alert to safety announcements.
If you're unsure about your prescription, don't hesitate to ask your pharmacist. They can confirm whether your bottle is part of the recall and help you get a safe replacement. Remember, your health is not something to gamble with.
